SUMMARY A strain of Bacteroidesfragilis with high-level chromosomal resistance to rifampicin was isolated by blood culture from a patient with bacteraemia after gastrointestinal surgery. He had been receiving antituberculous therapy with rifampicin for nine months. This resistance led to some difficulty in the recognition and identification of the isolate by methods that depended upon antibiotic sensitivity patterns. resected, and an end-to-end anastomosis was performed. Antituberculous therapy was stopped and peroperative prophylactic cefazolin (one dose of 1 g by intramuscular injection) and metronidazole (1 g by rectal suppository) were given; metronidazole was continued until the seventh postoperative day. The patient was discharged home on the ninth postoperative day. Four days later he was readmitted with severe abdominal pain, vomiting, and diarrhoea. At a second laparotomy the bowel anastamosis was found to have broken down and leaked. The anastamosis was resected and an ileostomy and mucous fistula were fashioned. Three doses of peroperative prophylactic cefazolin (1 g intramuscularly) and metronidazole (1 g per rectum) were again given.
Bacteroides fragilis is the major cause of postoperative sepsis after abdominal surgery.1 2 Serious complications ofthese infections include bacteraemia. The commonest source of bacteroides bacteraemia is lower gastrointestinal perforation, surgery, or other serious pathology, and it commonly follows appendicitis, diverticulitis, or colon surgery, especially for carcinoma.3 The antibiotic sensitivity of the Bacteroides spp. isolated from these infections is important. The infections are serious and require treatment, but the antibiotic sensitivity patterns are also very useful in the preliminary recognition and identification of Bacteroidaceae.4-7
Case history A 37-year-old man presented with a two-day history of abdominal pain and vomiting. His previous medical history included pulmonary tuberculosis, for which he Blood cultures were taken on the first, second, and third postoperative days because of episodes of pyrexia, hypotension, tachycardia, and rigors, and treatment with gentamicin and metronidazole was started on the fifth postoperative day. Approximately 5 ml of venous blood was seeded into each of two media: (a) 50 ml of brain-heart infusion broth (Gibco) with 10% sucrose and 1 % sodium polyanethol sulphonate (Liquoid), and (b) 90 ml of brain-heart infusion broth with 0 1 % sodium thioglycollate, 0-1 % glucose, 0 05 % agar, and methylene blue (for anaerobes). Both media were incubated at 37°C in air. After two days there was no macroscopic evidence of bacterial growth, and no microorganisms were seen in Gram-stained smears from the cultures. First subcultures were made after incubation for four days on to 5 % horse-blood agar incubated in air plus 5 % C02 and 5 % horseblood agar with 0-05% cysteine and 0-5% yeast extract, incubated anaerobically ('Gaspak' system). After 20 hours numerous small (<2 mm diam.), grey, lustreless colonies were found only on-the anaerobic subculture from medium (b) of the cultures taken on the second postoperative day; a Gram-stained smear showed small Gram-negative bacilli. Disc sensitivity testing showed that the organism was sensitive to metronidazole, cefoxitin, clindamycin, erythromycin, and tetracycline; therefore gentamicin therapy was stopped. Metronidazole treatment was continued for 16 days, and the patient was discharged three weeks after the second operation. Attempts to identify the isolate by the Mastring system8 gave an anomalous result; it was sensitive only to erythromycin and resistant to colistin, kanamycin, benzyl penicillin, rifampicin, and vancomycin whereas typical strains of the B. fragilis group are sensitive to erythromycin and rifampicin.
It was identified as B. fragilis (formerly B. fragilis ss. fragilis) by a combined set of tolerance, antibiotic disc resistance, biochemical, and fermentation tests ( 
